Table 2.
The mean bone-healing rate and infection eradication rate following single-stage and two-stage revision.
| Bone healing | Infection | Secondary | |
|---|---|---|---|
| (%) | eradication (%) | procedures (%) | |
| Single-stage | 705/881 (80.0) | 964/1109 (86.9) | 328/1173 (28.0) |
| Conventional implants | 374/465 (80.4) | 611/694 (88.0) | 224/709 (31.6) |
| Custom-made PMMA-coated implants | 331/416 (79.6) | 353/415 (85.0) | 104/464 (22.4) |
| Conventional | 215/257 (83.7) | 226/267 (84.6) | 62/233 (26.6) |
| Non-conventional | 116/159 (73.0) | 127/148 (85.8) | 42/165 (25.5) |
| Presumed aseptic fracture non-unions |
69/99 (70.0) |
61/76 (80.3) |
30/99 (30.3) |
| Two-stage | 140/181 (77.3) | 147/181 (81.2) | 36/142 (25.4) |
| Conventional implants | 14/24 (58.3) | 14/24 (58.3) | 10/15 (67.0) |
| Custom-made PMMA-coated implants | 126/157 (80.3) | 133/157 (84.7) | 26/127 (20.5) |
| Conventional | 72/86 (83.7) | 73/86 (84.9) | 16/86 (18.6) |
| Non-conventional | 54/71 (76.0) | 60/71 (84.5) | 10/41 (24.4) |
The means are an approximation based on the results described per study. In cases where studies did not explicitly describe the outcomes of patients relevant to the present study, the available outcomes of the (sub)cohort with the closest resemblance to the population of interest were reported.